Rhenman & Partners Asset Management AB - ACHILLION PHARMACEUTICALS IN ownership

ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 143 filers reported holding ACHILLION PHARMACEUTICALS IN in Q4 2019. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.

Quarter-by-quarter ownership
Rhenman & Partners Asset Management AB ownership history of ACHILLION PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2019$1,000,000
+34.2%
277,8000.0%0.12%
+52.4%
Q2 2019$745,000
-9.4%
277,8000.0%0.08%
-14.6%
Q1 2019$822,000
+28.4%
277,800
-31.0%
0.10%
+31.5%
Q4 2018$640,000
-71.9%
402,800
-34.8%
0.07%
-68.0%
Q3 2018$2,274,000
+30.1%
617,8000.0%0.23%
+27.4%
Q2 2018$1,748,000
-29.5%
617,800
-7.5%
0.18%
-41.3%
Q1 2018$2,478,000
+28.9%
667,8000.0%0.30%
+17.3%
Q4 2017$1,923,000
-49.6%
667,800
-21.4%
0.26%
-46.6%
Q3 2017$3,817,000
+400.9%
850,000
+412.0%
0.49%
+346.8%
Q2 2017$762,000
+9.0%
166,0000.0%0.11%
-1.8%
Q1 2017$699,000
+1.9%
166,0000.0%0.11%
-15.9%
Q4 2016$686,000
-100.0%
166,000
-37.6%
0.13%
-61.4%
Q3 2016$2,154,600,000
+103736.1%
266,0000.0%0.34%
-7.1%
Q2 2016$2,075,000
+1.0%
266,0000.0%0.37%
-9.8%
Q1 2016$2,054,000
-28.4%
266,0000.0%0.41%
-6.0%
Q4 2015$2,870,000
+48.3%
266,000
-5.0%
0.43%
+40.9%
Q3 2015$1,935,000
-22.0%
280,0000.0%0.31%
+3.4%
Q2 2015$2,481,000
-10.1%
280,0000.0%0.30%
-36.1%
Q1 2015$2,761,000
-38.8%
280,000
-23.9%
0.47%
-64.3%
Q4 2014$4,508,000
+125.9%
368,000
+84.0%
1.31%
+123.8%
Q3 2014$1,996,000
-20.1%
200,000
-39.4%
0.58%
-21.2%
Q2 2014$2,498,000330,0000.74%
Other shareholders
ACHILLION PHARMACEUTICALS IN shareholders Q4 2019
NameSharesValueWeighting ↓
RA Capital Management 12,033,220$92,896,00011.87%
RTW INVESTMENTS, LP 2,558,859$19,754,0007.17%
TURNER INVESTMENTS LLC 859,560$6,636,0001.80%
DAFNA Capital Management LLC 236,500$1,826,0001.58%
Ghost Tree Capital, LLC 250,000$1,930,0001.09%
Orbimed Advisors 11,519,700$88,932,0000.94%
Rock Springs Capital Management LP 1,220,000$9,418,0000.79%
Opus Point Partners Management, LLC 99,000$764,0000.59%
Bellevue Group AG 420,000$3,242,0000.59%
Cormorant Asset Management, LP 500,000$3,860,0000.58%
View complete list of ACHILLION PHARMACEUTICALS IN shareholders